[The effect of xylazine and disopyramide on the toxicity and biotransformation of methyl parathion in rats (author's transl)].
D000818:Animals; D001711:Biotransformation / Q000187:drug effects; D002265:Carboxylic Ester Hydrolases / Q000378:metabolism; D002802:Cholinesterases / Q000097:blood; D004206:Disopyramide / Q000494:pharmacology*; D008099:Liver / Q000378:metabolism; D008297:Male; D008743:Methyl Parathion / Q000378:metabolism / Q000633:toxicity*; D010278:Parathion / Q000031:analogs & derivatives*; D011725:Pyridines / Q000494:pharmacology*; D051381:Rats; D013843:Thiazines / Q000494:pharmacology*; D014991:Xylazine / Q000494:pharmacology*
D011725:Pyridines; D013843:Thiazines; D014991:Xylazine; D008743:Methyl Parathion; D010278:Parathion; D002265:Carboxylic Ester Hydrolases; D002802:Cholinesterases; D004206:Disopyramide
Der Effekt von Xylazin und Disopyramid auf Toxizität und Biotransformation von Parathion-methyl bei Raten.